Breaking Down MYS Group Co., Ltd. Financial Health: Key Insights for Investors

Curious whether MYS Group Co., Ltd. (002303.SZ) is a resilient mid-cap play or a cautionary tale for investors? The company reported revenue of CNY 1.05 billion in the quarter ending September 30, 2025 (down 4.04% YoY) while its trailing twelve months revenue reached CNY 4.06 billion (up 5.54% YoY) within a market cap of CNY 6.54 billion; profitability shows a 2024 net income of CNY 281.6 million and EPS of CNY 0.1839, paired with a modest ROE of 6.4% and net profit margin of 7.1%, yet the balance sheet reveals total assets of CNY 7.3 billion against liabilities of CNY 2.73 billion and a debt-to-equity ratio of 29.1% while the troubling interest coverage ratio sits at -54.2, liquidity metrics include CNY 1.6 billion in cash and short-term investments and operating cash flow of CNY 448.8 million, and growth levers such as 711 patents and a broad geographic footprint underpin its "packaging + health" strategy-read on to unpack how these figures translate into investment opportunities and risks.

MYS Group Co., Ltd. (002303.SZ) - Revenue Analysis

• Quarter (Q3 2025): CNY 1.05 billion (-4.04% YoY)
• TTM Revenue: CNY 4.06 billion (+5.54% YoY)
• FY 2024 Revenue: CNY 4.01 billion (+14.07% YoY)
• Revenue per employee: ~CNY 959,350 (4,236 employees)
• Price-to-Sales (P/S) ratio: 1.61
• Market capitalization: CNY 6.54 billion (mid-cap)

• Short-term: Q3 revenue dip suggests near-term volatility relative to last year's quarter.
• Medium-term: TTM growth of 5.54% shows underlying expansion despite quarterly softness.
• Efficiency: Revenue per employee (~CNY 959k) indicates operational productivity benchmarks for comparison within the sector.
• Valuation context: P/S of 1.61 and market cap CNY 6.54 billion position MYS Group in a balanced mid-cap valuation band.

MYS Group Co., Ltd. (002303.SZ) - Profitability Metrics

• Net income (FY 2024): CNY 281.60 million (vs CNY 196.09 million in 2023)
• Basic EPS (FY 2024): CNY 0.1839 (vs CNY 0.1281 in 2023)
• Return on Equity (ROE, 2024): 6.4%
• Net profit margin (2024): 7.1%
• TTM operating revenue: CNY 3.977 billion
• TTM gross profit: CNY 1.061 billion
• TTM selling, general & administrative expenses (SG&A): CNY 561.33 million

For broader context on the company's background and business model, see: MYS Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

MYS Group Co., Ltd. (002303.SZ) - Debt vs. Equity Structure

• Total shareholder equity: CNY 4.6 billion
• Total debt (interest-bearing): CNY 1.3 billion
• Debt-to-equity ratio: 29.1%
• Total assets: CNY 7.3 billion
• Total liabilities: CNY 2.73 billion
• Cash and short-term investments: CNY 1.6 billion
• Market capitalization: CNY 6.54 billion
• Interest coverage ratio (EBIT / Interest): -54.2

• Leverage profile: Low to moderate leverage (29.1% debt/equity) supports financial flexibility.
• Liquidity buffer: CNY 1.6 billion in cash and equivalents covers a large portion of total liabilities (≈58.6%), reducing short-term funding risk.
• Coverage risk: Interest coverage of -54.2 signals operating losses or very low EBIT relative to interest expense - a red flag for earnings-based solvency despite balance-sheet liquidity.
• Market valuation context: Market cap of CNY 6.54 billion vs. equity of CNY 4.6 billion implies a price-to-book ratio ≈1.42, reflecting market premium over book equity.

MYS Group Co., Ltd. (002303.SZ) - Liquidity and Solvency

MYS Group presents a liquidity profile characterized by a current ratio of 1.40, positive operating cash flow, and a balance-sheet scale that yields a moderate leverage level. Key raw figures:

• Current ratio: 1.40 - indicates the company has CNY 1.40 in current assets for every CNY 1.00 of current liabilities.
• Cash flow from operating activities: CNY 448.8 million - positive cash generation from core operations.
• Total liabilities: CNY 2.73 billion - total obligations to creditors.
• Total assets: CNY 7.3 billion - total resources controlled by the company.
• Quick ratio: not specified (typically lower than the current ratio once inventory is excluded).
• Cash ratio: not specified (measures ability to cover short-term obligations with cash and cash equivalents).

• Interpretation: A current ratio of 1.40 generally suggests adequate short-term liquidity, but the absence of quick and cash ratios prevents a full view of near-cash coverage; inventory reliance could materially change short-term flexibility.
• Positive operating cash flow (CNY 448.8m) supports liquidity beyond balance-sheet snapshots, indicating operations generate cash to service part of liabilities and fund working capital.
• The implied debt-to-assets ratio (~37.4%) signals moderate leverage - not highly leveraged, but creditors represent a meaningful claim on assets; monitor maturity profile and interest coverage in follow-ups.

Further context and investor-oriented detail are available here: Exploring MYS Group Co., Ltd. Investor Profile: Who's Buying and Why?

MYS Group Co., Ltd. (002303.SZ) - Valuation Analysis

• P/S = 1.61 places the company at ~1.6x sales - market pricing of top-line
• P/E = 19.90 implies investors are paying ~CNY 19.90 per unit of annual earnings
• EV (6.12 bn) below market cap (6.54 bn) - reflects net cash / liability balance embedded in EV
• ROE 6.4% and net margin 7.1% indicate moderate profitability relative to capital base
• Implied EV/Revenue (~1.51) is a useful cross-check against P/S for capital structure effects

MYS Group Co., Ltd. (002303.SZ) - Risk Factors

• Interest coverage ratio: -54.2 - EBIT is far below interest expense, signaling acute difficulty servicing interest from current operating earnings.
• Debt-to-equity ratio: 29.1% - moderate leverage but paired with weak interest coverage this leverage amplifies refinancing and solvency risk.
• Net profit margin: 7.1% - relatively low margin that limits earnings buffer against cost shocks or revenue declines.
• Return on equity (ROE): 6.4% - below many industry peers, indicating limited shareholder value generation given current equity base.
• Operating cash flow: CNY 448.8 million - positive but potentially insufficient to cover interest, dividends, capex and maturing liabilities without external funding.
• Total liabilities: CNY 2.73 billion - significant obligations that increase sensitivity to liquidity and market disruptions.

• Short-term liquidity risk: With negative interest coverage and large liabilities, near-term refinancing or covenant breaches are plausible if operating performance weakens.
• Profitability pressure: Low net margin and ROE constrain reinvestment and make the company vulnerable to margin compression from cost inflation.
• Cash flow adequacy: CNY 448.8M operating cash flow must cover interest, principal, capex and working capital - a tight profile given liabilities of CNY 2.73B.
• Market/perception risk: Continued weak coverage ratios can raise funding costs and reduce access to capital markets or bank facilities.
• Strategic execution risk: Any decline in revenue or cost overruns could quickly erode the slim profitability buffer and exacerbate leverage concerns.

MYS Group Co., Ltd. (002303.SZ) Growth Opportunities

• Innovation moat: 711 total patents - 84 invention patents, 611 utility model patents, 15 appearance patents, demonstrating sustained R&D and IP protection.
• Industry leadership: principal drafting/participating drafting unit for 42 national packaging standards, reinforcing market influence and barriers to entry.
• Geographic strategic layout: operations and business coverage across key economic corridors and overseas markets to capture regional demand.
• Sector diversification: products and solutions serving a wide array of end markets, reducing concentration risk and enabling cross-sector growth.
• Corporate footprint: more than 40 subsidiaries spanning Mainland China, Taiwan, Hong Kong, and the United States, supporting scale and localized service delivery.
• "Packaging + health" strategy: dual-wheel focus with investments into plant-based meat and health-related packaging opportunities aligned with global food and wellness trends.

• Near-term growth catalysts:
  • Expanding plant-based food packaging as global meat alternatives scale.
  • Leverage national standards role to win large institutional and OEM contracts.
  • Regional expansion (Mexico, SE Asia, South Asia) to capture trade shifts and nearshoring trends.
• Structural advantages:
  • Diversified end-market exposure insulates revenues from single-sector downturns.
  • Extensive IP and standards involvement support margin preservation and potential licensing income.
  • Localized subsidiaries enable cost optimization and faster customer response.